ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Predictors and Trends of MDR/RR-TB in Shenzhen China: A Retrospective 2012-2020 Period Analysis

Ji Lecai; Mijiti, Peierdun; Hong Chuangyue; Li Mingzhen; Gao Qian*; Tan Weiguo; Chen Jihong*复旦大学; 南方医科大学
Infection and Drug Resistance2021DOI: 10.2147/IDR.S335329
7被引12阅读
引用收藏
分享

摘要

Purpose: We analyzed the trends and predictors of multidrug-resistant (MDR) or rifampi-cin-resistant (RR) tuberculosis (TB) in culture-positive cases in Shenzhen during 2012-2020, after the implementation of improved strategies (scale-up molecular drug susceptibility testing [mDST], expansion of DST eligibility, and generous reimbursement of MDR-TB outpatient care costs). @@@ Materials and Methods: We retrospectively extracted and analyzed data from the TB Information System on drug-resistant pulmonary tuberculosis diagnosed in Shenzhen during the 2012-2020 period. We analyzed trends in RR-and MDR-TB rates in new cases during 2012-2018 and 2018-2020 periods, and among previously-treated cases during 2012-2017 and 2017-2020 periods, using Cochran-Armitage tests. We generated multivariate logistic regression models to analyze demographic predictors of MDR/RR-TB rates. @@@ Results: We found 21,367 positive mycobacterial cultures in Shenzhen during the 2012- 2020 period, and 19,951 (93.4%) were identified as Mycobacterium tuberculosis and had DST results (92.0% of those were mDST-based). Of these patients with DST results, 1630 (8.2%) were RR-TB, and 1142 (5.7%) were MDR-TB. Of the RR-TB, 70% were MDR-TB. The MDR/RR-TB rate in new TB cases increased significantly during the 2012-2018 period (Ptrend 0.05), but it decreased in the 2018-2020 period (P-trend 0.05, with a significant trend for MDR-TB). Among previously treated cases, the temporal MDR/RR-TB rate trends did not differ significantly (P-trend > 0.05). Our multivariate analysis showed that age younger than 30 years, housework service/unemployment, local residency, and previous TB treatment were all predictors of MDR/RR-TB. The percentage of patients with MDR-TB on treatment increased from 49.4% in 2012 to 70.5% in 2020. The treatment success rate of patients with MDR-TB during the 2012-2018 period was 71%. @@@ Conclusion: During the study period in Shenzhen, the cases of MDR/RR-TB were detected, and the treatment enrollment increased and the MDR-TB rates decreased gradually after 2017. Decreasing trends may reflect the efficacy of improved strategies; however, their long-term impact on the MDR-TB burden remains to be investigated. The predictors of MDR-TB identified in our study should be considered when developing targeted MDR-TB control strategies.

学科与关键词

关键词
MDR/RR-TBtrendpredictorsShenzhen2012-2020
相关
加载中…
  • Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in Shenzhen, China: a retrospective cohort study
    Lecai, Ji; Mijiti, Peierdun; Chuangyue, Hong; Qian, Gao*; Weiguo, Tan; Jihong, Chen*Frontiers in Public Health, 2023, 11: 1134938.被引 3
  • Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study
    Ou, Ze-Jin; Yu, Dan-Feng; Liang, Yuan-Hao; He, Wen-Qiao; Li, Yong-Zhi; Meng, Ya-Xian; Xiong, Hu-Sheng; Zhang, Min-Yi; He, Huan; Gao, Yu-Han; Wu, Fei; Chen, Qing*Infectious Diseases of Poverty, 2021, 10(1): 24.被引 17
  • Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia
    Bykov, Ilia; Dyachenko, Olga; Ratmanov, Pavel; Liu, Huan; Liang, Libo; Wu, Qunhong*BMC INFECTIOUS DISEASES, 2022, 22(1): 612.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Infection and Drug Resistance
发表日期
2021
卷期
第 14 卷
页码
4481-4491
DOI
10.2147/IDR.S335329
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Sanming Project of Medicine in Shenzhen [SZSM201611030]; Guangdong Medical Science and Technology Research Fund [B2021075]

作者

  • J

    Ji Lecai (第一作者)

    2 · southern med univ

  • M

    Mijiti, Peierdun

    fudan univ

查看全部 7 位作者收起作者
  • H

    Hong Chuangyue

  • L

    Li Mingzhen

  • G

    Gao Qian (通讯)

    fudan univ

  • T

    Tan Weiguo

  • C

    Chen Jihong (通讯)

    2 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417